Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Initial Treatment Approach for Nephrotic and Nephritic Syndrome

Diagnostic Approach

  • The American Academy of Pediatrics and Kidney International recommend confirming nephrotic-range proteinuria with 24-hour urine collection or spot urine protein-to-creatinine ratio 2
  • Investigations should be performed to exclude secondary causes, such as diabetes, lupus, infections, and medications, as suggested by Kidney International 2
  • In adults, kidney biopsy is generally indicated before initiating immunosuppressive therapy, according to Kidney International 2
  • In children with typical presentation, biopsy may be deferred if there is response to initial steroid therapy, as recommended by the American Academy of Pediatrics and Kidney International 2, 3
  • Biopsy is indicated in steroid-resistant nephrotic syndrome in children, as suggested by Kidney International 4

Initial Corticosteroid Protocol

  • The Kidney International guidelines recommend administering prednisone/prednisolone at 1 mg/kg/day (maximum 80 mg) or alternate-day dose of 2 mg/kg (maximum 120 mg) for adults 1, 2
  • High-dose corticosteroids should be continued for a minimum of 4 weeks if complete remission is achieved, and up to 16 weeks if remission is not achieved, as recommended by Kidney International 1
  • After achieving remission, steroids should be tapered slowly over a period of up to 6 months, according to Kidney International 1

Management of Steroid-Resistant Nephrotic Syndrome

  • Steroid resistance is defined after a minimum of 8 weeks of treatment with corticosteroids, as suggested by Kidney International 4
  • For steroid-resistant cases, calcineurin inhibitors (CNIs) are recommended as initial therapy, according to Kidney International 4
  • CNI therapy should be continued for a minimum of 6 months and then stopped if remission is not achieved, as recommended by Kidney International 4
  • If at least partial remission is achieved by 6 months, continue CNIs for a minimum of 12 months, according to Kidney International 4

Infection Prevention

  • Pneumococcal vaccination should be administered, as recommended by the American Academy of Pediatrics and Kidney International 2
  • Annual influenza vaccination should be given to patients and household contacts, according to the American Academy of Pediatrics and Kidney International 2
  • Live vaccines are contraindicated in children receiving immunosuppressive agents, as suggested by Kidney International 4

Monitoring and Follow-up

  • Regularly assess proteinuria and kidney function to evaluate treatment response, as recommended by the American Academy of Pediatrics and Kidney International 2
  • Monitor for side effects of medications, particularly with long-term immunosuppressive therapy, according to the American Academy of Pediatrics and Kidney International 2